Amino acid replacement: I954F.
Missense mutation of a conserved isoleucine within the kinase domain of dop.
A15571797T
I954F | dop-PA; I954F | dop-PB
I954F
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
Mutants are female sterile, embryonic lethal and produce membrane growth defects in cellularization. Adults show variable wing and leg defects.
dop1 mutant embryos exhibit delayed growth of malformed furrows during cellularization. Furrow widths are unimpaired during syncitial development, but during cellularization they are significantly wider and irregular compared to controls.
Initiation of furrow formation is blocked in dop1 mutant embryos - furrow canals are absent during the first 20 min after the onset of cycle 14.
In early cellularization, there is no detectable difference in the distribution and size of the villous projections at the cell surface; however, towards the end of cellularization, long projections persist in dop1 mutants whereas the surface becomes smooth in wild type.
A low percentage of dop1 flies exhibit partial deletion of wing margins, particularly at the posterior, and defective wing venation.
Embryos derived from homozygous females show a severe delay in membrane ingression during cellularisation and have an abnormal lipid-droplet distribution during germ-band extension.
Flies homozygous or hemizygous for dop1 are viable, but embryos from dop1 mothers do not hatch and display defects in larval cuticle formation. There are no significant differences between wild-type and dop1 mutant embryos up to cycle 13. However, events at the midblastula transition are affected in the mutant embryos. For example, the formation and growth of cell membranes at the start of and during cellularization is defective. dop1 embryos are abnormally transparent from gastrulation onward with lipid droplets highly enriched basally around the yolk sac, instead of being present throughout the embryo periphery. Wild-type and dop1 embryos display similar levels of transparency up until the end of cycle 14 and initial basal droplet transport is normal in the mutants. Therefore, a developmentally regulated switch in organelle transport appears to be defective in dop1 embryos at the end of cellularization.
Developmental defects occur during the transition from the syncytial to cellular blastoderm, causing abnormal cellularization. The distinct separation of the yolk and cortical cytoplasm breaks down followed by the irregular distribution of somatic nuclei.
Embryos derived from homozygous females show defects in cellular blastoderm formation. Cycle 14 embryos contain multiple nuclei that have been displaced from the peripheral monolayer and show irregularities in the cortical cytoplasm. The membrane furrows invaginate to different levels, and the greatest depth of the furrows is substantially less than that seen in wild-type embryos. Despite the absence of a uniform monolayer of nuclei at the embryo surface, the cortical actin network does form, with only one nucleus present per cell. The nuclei of the mutant embryos fail to elongate normally.
The initial cytoplasmic clearing and distinct separation of the peripheral cytoplasm from the central yolk appears to occur normally in embryos derived from dop1/Df(3L)BK10 females during syncytial blastoderm formation. However, the normal uniform appearance of the cytoplasm is not maintained in the mutant embryos, and irregularities are seen soon after the nuclei enter cycle 14. With time, the yolk/cortical delimitation becomes more irregular and many nuclei become displaced from the peripheral monolayer.
Embryos derived from mutant females show variable cuticle differentiation, with defects ranging from a slightly deformed cuticle with normal abdominal denticle belts but showing head defects to severe abnormalities with missing abdominal cuticle and head defects.
dop[+]/dop1 is an enhancer of partially lethal - majority die | male phenotype of Df(1)roX2Δ, lncRNA:roX1ex33A
dop1 has wing margin phenotype, enhanceable by sw1/sw1
dop1 has membrane | embryonic stage 5 phenotype, enhanceable by sw1
dop1 has membrane | embryonic stage 5 phenotype, enhanceable by DCTN1-p150Gl-1
dop[+]/dop1 is an enhancer of eye phenotype of DCTN1-p150Gl-1
dop[+]/dop1 is an enhancer of wing margin phenotype of sw1
dop1/dop1 is an enhancer of wing margin phenotype of sw1
The survival of roX1ex33A Df(1)roX2Δ adult males is reduced if they are also heterozygous for dop1.
dop1 complements AGO2321.
dop1 complements AGO2454.